Sparton Corp. (SPA) Drops 18.62% on February 08

Equities Staff |

Sparton Corp. (SPA) was one of the Russell 2000's biggest losers for Monday February 08 as the stock slid 18.62% to $12.15, a loss of $-2.78 per share. Starting at an opening price of $12.68 a share, the stock traded between $11.19 and $12.68 over the course of the trading day. Volume was 291,061 shares over 1,763 trades, against an average daily volume of 54,768 shares and a total float of 9.89 million.

The losses send Sparton Corp. down to a market cap of $120.19 million. In the last year, Sparton Corp. has traded between $29.49 and $14.52, and its 50-day SMA is currently $19.09 and 200-day SMA is $23.17.

The stock has a P/E Ratio of 12.4.

Sparton Corp is a provider of design, development, and manufacturing services for complex electromechanical devices and engineered products. The Company serves the medical & biotechnology, military & aerospace and industrial & commercial markets.

Sparton Corp. is based out of Schaumburg, IL and has some 1,823 employees. Its CEO is Cary B. Wood.

For a complete fundamental analysis analysis of Sparton Corp., check out’s Stock Valuation Analysis report for SPA. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Kiwa Bio-Tech Products Group Corp

Kiwa Bio-Tech Products Group Corp develops, manufactures, distributes and markets, cost-effective and environmentally safe bio-technological products for agriculture in China.

Private Markets


Wealthfront is an automated investment service that serves as an alternative to traditional financial advisory services. The company manages a diversified, continually rebalanced portfolio of index funds on their clients’…


Cloudera offers enterprises a new data platform built on the Apache Hadoop open-source software package. Hadoop is a data-management platform that can consolidate data in a single repository for comprehensive…